The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 151 - 180 of 368 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
|
|
European Medicines Agency's website: Teriflunomide Viatris (ent. Teriflunomide Mylan) - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Teriflunomide Vivanta 14 mg tabletti, kalvopäällysteinen PL 2024-08-08
|
PL
|
Resepti
|
Teriflunomide Vivanta 14 mg tabletti, kalvopäällysteinen SPC 2024-08-08
|
PL
|
Resepti
|
Terlipressin SUN 1 mg injektioneste, liuos SPC 2022-07-05
|
PL
|
Resepti
|
Terolut 10 mg tabletti kalvopäällysteinen SPC 2024-01-24
|
PL
|
Resepti
|
Terra-Cortril-P korva-silmätipat, suspensio SPC 2024-06-24
|
PL
|
Resepti
|
Terra-Cortril-P korva-silmävoide SPC 2024-06-24
|
PL
|
Itsehoito
|
Terracort voide SPC 2024-06-24
|
|
|
European Medicines Agency's website: Terrosa - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tesavel - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Testavan 20mg-g transdermaaligeeli SPC 2023-09-06
|
PL
|
Resepti
|
Testogel 16,2 mg-g transdermaaligeeli SPC 2022-07-22
|
PL
|
Resepti
|
Testogel 25 mg-annos, 50 mg-annos transdermaaligeeli SPC 2021-12-16
|
PL
|
Resepti
|
Testonur 1000 mg-4 ml injektioneste, liuos SPC 2024-05-22
|
PL
|
Resepti
|
Testosterone Orifarm 1000 mg-4 ml injektioneste, liuos SPC 2024-01-23
|
PL
|
Resepti
|
Testosterone ratiopharm 1000 mg - 4 ml injektioneste, liuos SPC 2023-07-03
|
PL
|
Resepti
|
Tetmodis 25 mg tabletti SPC 2022-04-25
|
PL
|
Resepti
|
Tetralysal 150 mg kapseli, kova SPC 2021-10-29
|
PL
|
Resepti
|
Tetralysal 300 mg kapseli, kova SPC 2021-10-29
|
PL
|
Resepti
|
Tetravac injektioneste, suspensio, esitäytetty ruisku SPC 2024-04-26
|
PL
|
Resepti
|
Tetrofosmin Rotop 0,23 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2022-02-09
|
|
|
European Medicines Agency's website: Tevagrastim - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Teveten 600 mg tabletti, kalvopäällysteinen SPC 2022-02-03
|
PL
|
Resepti
|
Teveten Comp 600 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2023-02-07
|
|
|
European Medicines Agency's website: Tevimbra - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Teysuno - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tezspire - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Thalidomide BMS (ent. Thalidomide Celgene, ent. Thalidomide Pharmion) - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Thalidomide Lipomed - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Thallous Ti-201 Chloride 37 MBq-ml injektioneste SPC 2022-12-09
|
|